Prescriber Uptake and Use of Novel Lipid‐Lowering Therapies
Background The uptake of novel lipid‐lowering therapy (LLT) has been low; however, variations in clinician prescribing patterns have not been well studied. This study sought to describe early prescribing patterns of novel LLT and identify factors associated with high usage. Methods We identified pre...
Saved in:
| Main Authors: | Jimin Hwang, Eric D. Peterson, Anand Gupta, Emily Decicco, Evelyn Sarnes, Ann Marie Navar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.125.040768 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular risk management beyond statins: review of new therapies available in Italy
by: Maurizio Capuozzo, et al.
Published: (2025-07-01) -
Effectiveness of inclisiran lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Moscow healthcare
by: A. I. Sapina, et al.
Published: (2024-06-01) -
The importance of paying attention to the role of lipid-lowering drugs in controlling dengue virus infection
by: Omer Qutaiba B. Allela, et al.
Published: (2024-12-01) -
Features of lipid-lowering therapy in liver transplant recipients
by: A. A. Kucherov, et al.
Published: (2023-12-01) -
PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
by: Simon Rauterberg, et al.
Published: (2025-01-01)